Rapid Dose Therapeutics Corp. (RDTCF)
OTCMKTS · Delayed Price · Currency is USD
0.1393
-0.0407 (-22.61%)
At close: Apr 8, 2025
Rapid Dose Therapeutics Revenue
In the fiscal year ending February 28, 2025, Rapid Dose Therapeutics had annual revenue of 2.09M CAD with 104.34% growth. Rapid Dose Therapeutics had revenue of 668.58K in the quarter ending February 28, 2025, with 247.04% growth.
Revenue
2.09M CAD
Revenue Growth
+104.34%
P/S Ratio
12.95
Revenue / Employee
n/a
Employees
n/a
Market Cap
18.71M USD
Revenue Chart
* This company reports financials in CAD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo, Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 84.04M |
Glass House Brands | 215.62M |
Northwest Biotherapeutics | 1.47M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.70M |
Rapid Dose Therapeutics News
- 16 days ago - Rapid Dose Announces Payment in Shares for Quarterly Interest on Secured Debt - Newsfile Corp
- 6 months ago - Rapid Dose Announces Payment in Shares for Quarterly Interest on Secured Debt - Newsfile Corp
- 2 years ago - Rapid Dose Announces Proposed Private Placement Financing - Business Wire
- 2 years ago - Rapid Dose Therapeutics Provides Update on Failure to File Cease Trade Order - Business Wire
- 3 years ago - Rapid Dose Therapeutics to Participate in the Venture Mentoring Services Program in Partnership with Maryland Tech Council and Canada's Trade Commissioner Service - Business Wire
- 3 years ago - Rapid Dose Therapeutics Enters Supplier and Purchase Agreement with a Leading Gas and Convenience Store Retailer for Nutraceutical and Vitamin Products - Business Wire
- 3 years ago - Rapid Dose Therapeutics Confirms Delay in Filing Annual Financial Statements and Issuance of Failure-to-File Cease Trade Order - Business Wire
- 3 years ago - Rapid Dose Therapeutics Provides Bi-Weekly MCTO Status Update - Business Wire